Team

Andrea Senaldi

Paul Kinnon

CEO
Paul has over 30 years of experience in the global life sciences industry, with the past 20 years of his executive career focused on Clinical Diagnostics and innovative products to improve patients’ lives. He has held leadership positions within PredictImmune, Transgenomic, ZyGEM Corp., Life Technologies (now ThermoFisher), Guava Technologies and Cellomics, raising more than $70m in funding, creating global partnerships and increasing shareholder return. Paul has spent half of his career living and working in the USA running global businesses, which gives him a novel and unique outlook on the global industry; additionally he sits on a number of Boards as non-executive director (NED) for Life Science companies.
Simona Piccirella

Simona Piccirella

PhD, VP Product Development and Operations
Experienced manager with profound knowledge of life science sector. In 2009 she co-founded the company VisMederi srl and she was COO until 2016, serving clients such as Sanofi, Novartis, GSK, Takeda in vaccine immunogenicity evaluation and analytical assay validation.
Pierre-Edouard Jumel

Pierre-Edouard Jumel

CFO
+15 years experience in CFO roles in various industries, in different economic context (high speed growth, consolidating, restructuring, etc) and of various size (startup, scale up and multinationals) around the globe (France, Italy, Mexico and China). Expertise in communicating with Leadership team, BoD and Shareholders and monitoring and managing daily cash and debt financing, in building FP&A & BI, in supervising local GAAPs (French, Chinese and Italian), IFRS and financial procedures, in designing governance and leading special projects (cross-border M&A, equity funding, etc).
Daniela Uberti

Prof. Daniela Uberti

Co-founder and CSO
Seasoned researcher and well known professor. She is Associate Professor at the University of Brescia (Molecular and Translational Medicine Dept). She worked at the Weizmann Institute of Science in Israel. She is the main inventor of Diadem's Technology. Her impact index is 24,7.